Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Idiopathic pulmonary fibrosis (IPF) and herpesvirus saimiri: an interview with Elazar Rabbani, Chief Executive Officer of Enzo

Pulmonary fibrosis is a condition where fibrotic or scarred tissue progressively develops in the lungs. In some cases the particular cause is known but in others it remains unknown and is given the term “idiopathic”.

14 Jan 2014

First Edition: January 13, 2014

Today's headlines include news about how the health law's enrollment process is working and about the federal government's decision not to renew the contract for the company that was overseeing the repairs for healthcare.gov.

13 Jan 2014

Study indicates some groups have specific genetic make-up that prevents from fighting off influenza

Research indicated that some Indigenous people such as in Alaska and Australia displayed limited immunity response to the effects of influenza.

13 Jan 2014

Sending text messages to low-income pregnant women result in uptick in influenza vaccination

A study by researchers at the Mailman School of Public Health evaluated the impact of text messaging reminders for influenza vaccine in a low-income obstetric population. The findings showed that sending text messages to this population of women resulted in an uptick in influenza vaccination, especially for those who received the messages early in their third trimester.

10 Jan 2014

Meridian's TRU FLU assay gets FDA clearance for analytical sensitivity claim for avian Influenza H7N9 strain

Meridian Bioscience, Inc. today announced that the company's TRU FLU assay received FDA clearance for an analytical sensitivity claim for the novel avian Influenza H7N9 strain, A/Anhui/1/2013. TRU FLU is a rapid immunoassay that detects influenza A and influenza B viruses in 15 minutes in human respiratory specimens.

10 Jan 2014

Viewpoints: Don't blame insurers for health system problems; Obama's 'management failure;' Texas abortion case heads to court

[The] problem with the Affordable Care Act isn't the insurance industry. In fact, the main benefits of nationalized health care can be achieved in systems with hundreds, even thousands, of for-profit insurers. ...

10 Jan 2014

PaxVax reports interim data from Phase 3 cholera challenge study of PXVX0200

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced interim data from a Phase 3 cholera challenge study of its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Trial investigators compared the rate of diarrhea in participants vaccinated with PXVX0200 to the rate in participants who had received placebo.

10 Jan 2014

Sutter Davis Hospital receives Malcolm Baldrige National Quality Award for excellent performance

Sutter Davis Hospital (SDH) has become the first organization in the greater Sacramento area and the smallest hospital ever to receive the Malcolm Baldrige National Quality Award, the nation's only Presidential honor that recognizes performance excellence in education, healthcare and business organizations.

10 Jan 2014

CalNaturale Svelte helps individuals looking to achieve new health goals in 2014

To ring in the New Year and help make health and fitness resolutions stick through the winter and beyond, CalNaturale Svelte®, the premium line of USDA Certified organic protein shakes that provides great taste, sustained nutrition and energy through pure and simple ingredients, is offering simple ways for people to stay "Svelte" this season.

10 Jan 2014

Brown University biochemist targets diabetes

People with type 2 diabetes can make insulin but their bodies use it so poorly that glucose levels run amok. It's been difficult for scientists to understand what's going awry in the way that tiny, fast-moving proteins signal and regulate glucose metabolism. As a result, while drugs can help somewhat, many patients still must monitor their glucose and inject insulin.

10 Jan 2014

Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

Hospice patients are expected to die: The treatment focuses on providing comfort to the terminally ill, not finding a cure. To enroll a patient, two doctors certify a life expectancy of six months or less. But over the past decade, the number of "hospice survivors" in the United States has risen dramatically, in part because hospice companies earn more by recruiting patients who aren't actually dying, a Washington Post investigation has found. Healthier patients are more profitable because they require fewer visits and stay enrolled longer (Peter Whoriskey and Dan Keating, 12/26).

9 Jan 2014

Monitoring air pollution now possible with technological advances in air quality measurement methods

Launching a natural research experiment in Kathmandu, Nepal, this month using advanced monitoring methods to assess health risk from air pollution, environmental health scientist Rick Peltier at the University of Massachusetts Amherst hopes to demonstrate for the first time in a real-world setting that air pollution can and should be regulated based on toxicology variables rather than simply on the volume of particles in the air.

9 Jan 2014

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.

9 Jan 2014

Working out while sick can actually do more harm than good, says professor

With the flu and cold season in full swing, kinesiology professor Karin Richards, at University of the Sciences in Philadelphia, said many people tend to ignore their symptoms to keep on track with their fitness resolutions for the New Year.

8 Jan 2014

Quick tips to avoid carbon monoxide poisoning

Temperatures in the next few days are predicted to be the coldest of the winter so far, and people using space heaters to get some extra warmth into their living and working spaces need to be aware of a potential "silent killer" inside their homes and offices — carbon monoxide (CO).

8 Jan 2014

AIT initiates Phase II clinical trial of NOxCureCF for patients with cystic fibrosis

Advanced Inhalation Therapies, an Israeli drug development company, announced today that it has begun enrollment in Israel for a multicenter, open label, Phase II clinical trial of NOxCureCF, a respiratory treatment for patients with cystic fibrosis.

8 Jan 2014

IQWiG study finds no added benefit of teriflunomide

Teriflunomide (trade name: Aubagio) has been approved in Germany since August 2013 for adults with relapsing remitting multiple sclerosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA).

8 Jan 2014

Hospitals with higher rates of readmissions may suffer cut in Medicare payments by 2015

Hospitals that treat more poor seniors who are on both Medicaid and Medicare tend to have higher rates of readmissions, triggering costly penalties from the Centers for Medicare and Medicaid Services, finds a new study in Health Services Research.

8 Jan 2014

Landes Bioscience releases special issue on sepsis

A special issue on sepsis has been released by the publisher Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Virulence have been authored by world-class investigators and provide new insights into both the pathogen-related factors and the host defense mechanisms that lead to septic shock and contribute to its resolution or fatal outcome.

7 Jan 2014

First patient enrolled in the North American Phase 3 clinical trials for investigational flu treatment drug

BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.

7 Jan 2014

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Idiopathic pulmonary fibrosis (IPF) and herpesvirus saimiri: an interview with Elazar Rabbani, Chief Executive Officer of Enzo

First Edition: January 13, 2014

Study indicates some groups have specific genetic make-up that prevents from fighting off influenza

Sending text messages to low-income pregnant women result in uptick in influenza vaccination

Meridian's TRU FLU assay gets FDA clearance for analytical sensitivity claim for avian Influenza H7N9 strain

Viewpoints: Don't blame insurers for health system problems; Obama's 'management failure;' Texas abortion case heads to court

PaxVax reports interim data from Phase 3 cholera challenge study of PXVX0200

Sutter Davis Hospital receives Malcolm Baldrige National Quality Award for excellent performance

CalNaturale Svelte helps individuals looking to achieve new health goals in 2014

Brown University biochemist targets diabetes

Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

Monitoring air pollution now possible with technological advances in air quality measurement methods

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Working out while sick can actually do more harm than good, says professor

Quick tips to avoid carbon monoxide poisoning

AIT initiates Phase II clinical trial of NOxCureCF for patients with cystic fibrosis

IQWiG study finds no added benefit of teriflunomide

Hospitals with higher rates of readmissions may suffer cut in Medicare payments by 2015

Landes Bioscience releases special issue on sepsis

First patient enrolled in the North American Phase 3 clinical trials for investigational flu treatment drug

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in